Marika Niihori
We’re delighted to share that Nature Biotechnology has published a new Q&A on digital twins in medicine, featuring expert insights from across academia and industry – including Professor Mihaela van der Schaar.
The discussion explores how digital twins are being developed and deployed across areas such as oncology, diabetes, and cardiovascular medicine. It also highlights key challenges – from data availability and model validation to clinical translation and safety.
Prof van der Schaar shared her perspective on the opportunities and challenges ahead for digital twins, drawing on recent research from our lab specifically HDTwin and CALM-DT.
For readers new to this area, we’ve previously published an in-depth explainer – Understanding Digital Twins. This introduces the core concepts, applications, and ongoing work from the van der Schaar Lab.
Read the Q&A on Nature Biotechnology.
